Cooper misses quarterly revenue estimates on lower-than-expected contact lens sales

 Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.6% year on year to $964.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.12 billion at the midpoint. Its non-GAAP profit of $0.92 per share was in line with analysts’ consensus estimates.

CooperCompanies (COO) Q4 CY2024 Highlights:

• Revenue: $964.7 million vs analyst estimates of $980.4 million (3.6% year-on-year growth, 1.6% miss)

• Adjusted EPS: $0.92 vs analyst estimates of $0.91 (in line)

• The company reconfirmed its revenue guidance for the full year of $4.12 billion at the midpoint

• Management slightly raised its full-year Adjusted EPS guidance to $3.98 at the midpoint

• Operating Margin: 18.9%, up from 16.4% in the same quarter last year

• Organic Revenue rose 6% year on year (7.5% in the same quarter last year)

• Market Capitalization: $18.23 billion

• 
  

Commenting on the results, Al White, Cooper's President and CEO said, "We started the year on a positive note meeting our revenue expectations and exceeding our operational targets. Moving forward, we remain confident in our ability to deliver strong growth and operational excellence, and this is reflected in our guidance."

https://finance.yahoo.com/news/coopercompanies-nasdaq-coo-misses-q4-212520550.html